| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
2 companies
Brainard Diana is a Chief Executive Officer at Kalaris Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 3,075 | $0.75 | $2,304.10 | -0.4% | -5.8% | -80.5% | |
| May 3, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 10,240 | $0.80 | $8,151.04 | -1.3% | +0.3% | -68.2% | |
| Apr 19, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 9,601 | $0.75 | $7,206.51 | -1.2% | +1.3% | -61.7% | |
| Apr 2, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 1,533 | $0.77 | $1,183.48 | -0.2% | -4.9% | -54.3% | |
| Feb 21, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 8,252 | $0.70 | $5,803.29 | -0.5% | +11.8% | -40.0% | |
| Feb 5, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 41,421 | $0.67 | $27,752.07 | -4.8% | +20.3% | -34.7% | |
| Jan 23, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 9,500 | $0.67 | $6,368.80 | -1.1% | +13.9% | -40.3% | |
| Jan 4, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 1,664 | $0.64 | $1,063.30 | -0.2% | +14.3% | -32.4% | |
| Nov 20, 2023 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 7,071 | $1.67 | $11,793.80 | -0.4% | -57.1% | -65.9% | |
| Oct 19, 2023 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 8,581 | $1.58 | $13,557.98 | -1.0% | -57.0% | -50.8% |